The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment (Q36670132)

15 August 2017

1 reference

title

The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment (English)

1 reference

15 August 2017

The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment (English)

1 reference

6 November 2022

0 references

C. S. Lewin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713846

6 November 2022

I. Morrissey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713846

6 November 2022

J. T. Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713846

6 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1713846

6 November 2022

publication date

1 April 1991

1 reference

full work available at URL

15 August 2017

http://link.springer.com/content/pdf/10.1007/BF01966996.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01966996/fulltext.html

6 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01966996

6 November 2022

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

6 November 2022

published in

1 reference

15 August 2017

10

1 reference

15 August 2017

4

1 reference

15 August 2017

240-248

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01966996

15 August 2017

0 references

cites work

Investigations into the mechanism of action of the antibacterial agent norfloxacin

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Nalidixic Acid: an Antibacterial Paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Randomized evaluation of ceftazidime or ticarcillin and tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Effect of oral ofloxacin on fecal bacteria in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Inhibition of enoxacin absorption by antacids or ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Routes of quinolone permeation in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

In vitro activity of PD 127,391, an enhanced-spectrum quinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

In vitro activity of AT-4140 against clinical bacterial isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

In vitro activities of irloxacin and E-3846, two new quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01966996

Ciprofloxacin and antacids

21 January 2018

1 reference

12 December 2020

Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model

1 reference

12 December 2020

Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid

1 reference

12 December 2020

Induction of the SOS response by new 4-quinolones

1 reference

12 December 2020

Interactions between twisted DNAs and enzymes: the effects of superhelical turns

1 reference

12 December 2020

Reduced enteral absorption of ciprofloxacin in the presence of antacids

1 reference

12 December 2020

4-quinolones and the SOS response.

1 reference

12 December 2020

The effect of mutations in the SOS response on the kinetics of quinolone killing.

1 reference

12 December 2020

Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.

1 reference

12 December 2020

Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens.

1 reference

12 December 2020

DNA supercoiling and the anaerobic and growth phase regulation of tonB gene expression.

1 reference

12 December 2020

1 reference

12 December 2020

Mechanism of Action of Nalidixic Acid on Escherichia coli III. Conditions Required for Lethality

1 reference

12 December 2020

Mechanisms determining aerobic or anaerobic growth in the facultative anaerobe Salmonella typhimurium

1 reference

12 December 2020

Mechanisms of resistance to quinolones and clinical perspectives

1 reference

12 December 2020

DNA breakdown by the 4-quinolones and its significance.

1 reference

12 December 2020

MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI

1 reference

12 December 2020

The bactericidal activity of DR-3355, an optically active isomer of ofloxacin

1 reference

12 December 2020

Mechanism of Action of Nalidixic Acid on Escherichia coli IV. Effects on the Stability of Cellular Constituents

1 reference

12 December 2020

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

1 reference

12 December 2020

Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16.

1 reference

12 December 2020

An overlap between osmotic and anaerobic stress responses: a potential role for DNA supercoiling in the coordinate regulation of gene expression.

1 reference

12 December 2020

Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli

1 reference

12 December 2020

In vitro studies of S-25930 and S-25932, two new 4-quinolones.

1 reference

12 December 2020

1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

1 reference

12 December 2020

Accumulation of enoxacin by Escherichia coli and Bacillus subtilis

1 reference

12 December 2020

Bactericidal mechanisms of ofloxacin.

1 reference

12 December 2020

A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli

1 reference

12 December 2020

Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16

1 reference

12 December 2020

The accumulation of five quinolone antibacterial agents by Escherichia coli.

1 reference

12 December 2020

The in vitro and in vivo activity of ciprofloxacin

1 reference

12 December 2020

Electrochemical characteristics of five quinolone drugs and their effect on DNA damage and repair in Escherichia coli

1 reference

12 December 2020

Uptake of 14C-streptomycin by some microorganisms and its relation to their streptomycin sensitivity

1 reference

12 December 2020

Dihydrostreptomycin accumulation in E. coli

1 reference

12 December 2020

Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase

1 reference

12 December 2020

Mechanisms of action of and resistance to ciprofloxacin

1 reference

12 December 2020

Potential mechanisms of resistance to the modern fluorinated 4-quinolones

1 reference

12 December 2020

Ciprofloxacin: an overview of adverse experiences

1 reference

12 December 2020

1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents

1

1 reference

Inhibitors of DNA topoisomerases

6 November 2022

3

1 reference

American Journal of Medicine

6 November 2022

6

82

12

DG Hooper

1987

1 reference

Reviews of Infectious Diseases

6 November 2022

14

11

914

T Nishino

1989

1 reference

Bacterial mutagenicity and the 4-quinolones

6 November 2022

28

1 reference

6 November 2022

38

4

385

NT Ratcliffe

1985

1 reference

Reviews of Infectious Diseases

6 November 2022

40

11

913

CS Lewin

1989

1 reference

American Journal of Medicine

6 November 2022

42

82

254

DN Gilbert

1987

1 reference

6 November 2022

Identifiers

DOI

10.1007/BF01966996

1 reference

15 August 2017

1 reference